Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Xenograft Model Antitumor Assays. Found 21 abstracts

no pagination
Czyz M, Toma M, Gajos-Michniewicz A, Majchrzak K, Hoser G, Szemraj J, Nieborowska-Skorska M, Cheng P, Gritsyuk D, Levesque M, Dummer R, Sliwinski T, Skorski T. PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas. Oncotarget. 2016 Nov 15;7(46):75551-60.   PMCID: PMC5342760
Prabhu VV, Hong B, Allen JE, Zhang S, Lulla AR, Dicker DT, El-Deiry WS. Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated DeltaNp73 Inhibition and p73 Activation. Cancer Res. 2016 Apr;76(7):1989-99.
Prudnikova TY, Villamar-Cruz O, Rawat SJ, Cai KQ, Chernoff J. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells. Oncogene. 2016 Apr 28;35(17):2178-85.   PMCID: PMC5125076
Deng XB, Xiao L, Wu Y, Jin F, Mossman B, Testa JR, Xiao GH. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. International journal of cancer. 2015 Jul 15;137(2):481-90.   PMCID: PMC4428975
Gritsina G, Xiao F, O'Brien SW, Gabbasov R, Maglaty MA, Xu RH, Thapa RJ, Zhou Y, Nicolas E, Litwin S, Balachandran S, Sigal LJ, Huszar D, Connolly DC. Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth. Mol Cancer Ther. 2015 Apr;14(4):1035-47.   PMCID: PMC4394029
Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015 Jan;34(2):144-53.   PMCID: PMC4067476
Sasano T, Mabuchi S, Kuroda H, Kawano M, Matsumoto Y, Takahashi R, Hisamatsu T, Sawada K, Hashimoto K, Isobe A, Testa JR, Kimura T. Preclinical efficacy for AKT targeting in clear cell carcinoma of the ovary. Molecular Cancer Research. 2015 Apr;13(4):795-806.   PMCID: PMC4398602
Makhov P, Golovine K, Teper E, Kutikov A, Mehrazin R, Corcoran A, Tulin A, Uzzo RG, Kolenko VM. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. Br J Cancer. 2014 Feb 18;110(4):899-907.   PMCID: PMC3929888
Mantia-Smaldone G, Ronner L, Blair A, Gamerman V, Morse C, Orsulic S, Rubin S, Gimotty P, Adams S. The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse model. Gynecol Oncol. 2014 Jun;133(3):584-90.
Hensley HH, Hannoun-Levi JM, Hachem P, Mu Z, Stoyanova R, Khor LY, Agrawal S, Pollack A. PKA knockdown enhances cell killing in response to radiation and androgen deprivation. International journal of cancer. 2011 Feb 15;128(4):962-73.   PMCID: NIHMS236076
Arias-Romero LE, Villamar-Cruz O, Pacheco A, Kosoff R, Huang M, Muthuswamy SK, Chernoff J. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Oncogene. 2010 Oct 28;29(43):5839-49.   PMCID: PMC2965784
Balaburski GM, Dardes RC, Johnson M, Haddad B, Zhu F, Ross EA, Sengupta S, Klein-Szanto A, Liu H, Lee ES, Kim H, Jordan VC. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance. Int J Oncol. 2010 Aug;37(2):387-98.   PMCID: PMC3023309
Cordero AB, Kwon Y, Hua X, Godwin AK. In vivo imaging and therapeutic treatments in an orthotopic mouse model of ovarian cancer. Journal of visualized experiments : JoVE. 2010 Jan;(42).   PMCID: PMC2935696
Mu Z, Hachem P, Hensley H, Stoyanova R, Kwon HW, Hanlon AL, Agrawal S, Pollack A. Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo. The Prostate. 2008 May;68(6):599-609.
Adams GP, Shaller CC, Dadachova E, Simmons HH, Horak EM, Tesfaye A, Klein-Szanto AJ, Marks JD, Brechbiel MW, Weiner LM. A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.[see comment]. Cancer Research. 2004 Sep;64(17):6200-6.
Cheng JD, Dunbrack RL, Valianou M, Rogatko A, Alpaugh RK, Weiner LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 2002 Aug 15;62(16):4767-72.
Takahashi N, Li W, Banerjee D, Guan Y, Wada-Takahashi Y, Brennan MF, Chou TC, Scotto KW, Bertino JR. Sequence-dependent synergistic cytotoxicity of ET-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo. Cancer Res. 2002 Dec;62(23):6909-15.
Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 2001 Jun 15;61(12):4750-5.
Guo P, Ma J, Li S, Guo Z, Adams AL, Gallo JM. Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. Cancer Chemother Pharmacol. 2001 Aug;48(2):169-76.
Ma J, Pulfer S, Li S, Chu J, Reed K, Gallo JM. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res. 2001 Jul 15;61(14):5491-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Xenograft Model Antitumor Assays

Xenograft Model Antitumor Assays Mice metabolism pharmacology Tumor Cell Line Female pathology drug effects genetics Cell Proliferation drug therapy Ovarian Neoplasms Signal Transduction Nude Mice Apoptosis Male Animal Human US Gov't Support-PHS Breast Neoplasms Cell Survival antagonists & inhibitors Animal Disease Models SCID Mice administration & dosage physiology biosynthesis erbB-2 Receptor analogs & derivatives Tumor Suppressor Protein p53 immunology Tissue Distribution Prostatic Neoplasms Drug Synergism Cultured Tumor Cells Western Blotting Non-US Gov't Support Proto-Oncogene Proteins c-akt Antineoplastic Agents enzymology Multiprotein Complexes p21-Activated Kinases methods Neoplastic Stem Cells Nude Rats chemistry TOR Serine-Threonine Kinases Proto-Oncogene Proteins c-met Dacarbazine Phosphorylation Neoplasm Drug Resistance Neoplasm Transplantation deficiency Androgen Receptors Androgen Antagonists Hepatocyte Growth Factor Rats pharmacokinetics Cell Movement Isoquinolines Drug Interactions Doxorubicin Cisplatin derivatives pd [Pharmacology] Anti-Bacterial Agents Dioxoles Lung Neoplasms Raloxifene Hydrochloride Janus Kinases Clear Cell Adenocarcinoma Chloroquine Melanocytes Estrogen Antagonists Glioma Antibody Affinity Nuclear Proteins Orchiectomy Angiogenesis Inhibitors Inbred Strains Mice Melanoma Immunoenzyme Techniques im [Immunology] Androgens Radioimmunotherapy erbB-2) EC 2-7-1-112 (Receptor Reactive Oxygen Species GABA-A Receptors Gene Expression Profiling Genetic Therapy Ovarian cancer blood Camptothecin Disease Progression Cell Communication toxicity Drug Delivery Systems Antisense Oligodeoxyribonucleotides Fibroblasts aa [Analogs & Derivatives] Isothiocyanates 0 (Yttrium Radioisotopes) Non-US Gov't Research Support Cell Cycle Checkpoints DNA Repair Proto-Oncogene Proteins p21(ras) Carcinoma Integrin alphaVbeta3 P-Glycoprotein Pentetic Acid Luciferases Experimental Neoplasms Gamma Rays Serine Endopeptidases Immunohistochemistry Kinetics Piperazines Experimental Mammary Neoplasms dosage beta Catenin Aminopyridines Anilides Genetic Vectors Yttrium Radioisotopes Immunoglobulin Fragments Diagnostic Imaging HGF Growth Substances Sesquiterpenes Histones Paclitaxel therapy Sprague-Dawley Rats cancer stem-like cells Cellular Spheroids Autophagy Brca synthetic lethality PARP1 inhibitor Brain Neoplasms Inhibitory Concentration 50 Neoplastic Gene Expression Regulation HEK293 Cells Phthalazines Cell Division Double-Stranded DNA Breaks Antineoplastic Antibiotics Kidney Neoplasms Antineoplastic Antimetabolites Nk4
Last updated on Monday, May 04, 2020